Moderate Atopic dermatitis
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB14973 | Abrocitinib | A kinase inhibitor used to treat moderate-to-severe atopic dermatitis in adults. |
| DB11817 | Baricitinib | A Janus kinase inhibitor used to treat moderate to severe rheumatoid arthritis that has responded poorly to at least one TNF antagonist. |
| DB05219 | Crisaborole | A non-steroidal topical medication used for the treatment of mild-moderate atopic dermatitis. |
| DB01260 | Desonide | A topical corticosteroid used for the symptomatic treatment of inflammatory and pruritic manifestations of corticosteroid responsive dermatoses. |
| DB12159 | Dupilumab | A monoclonal antibody used to treat moderate to severe atopic dermatitis, asthma, and nasal polyps accompanied by chronic rhinosinusitis in adolescents and adults. |
| DB02703 | Fusidic acid | A topical antibacterial agent used to prevent and treat mild to moderate skin infections caused by susceptible bacteria. |
| DB00337 | Pimecrolimus | A topical calcineurin inhibitor used in the treatment of mild-moderate atopic dermatitis who are not candidates for other types of therapy due to previous lack of response or other reasons. |
| DB08877 | Ruxolitinib | A kinase inhibitor used to treat various types of myelofibrosis, polycythemia vera in patients who have not responded to or cannot tolerate hydroxyurea, and to treat graft-versus-host disease in cases that are refractory to steroid treatment. |
| DB00864 | Tacrolimus | A calcineurin inhibitor used to prevent organ transplant rejection and to treat moderate to severe atopic dermatitis. |
| Drug | Drug Name | Phase | Status | Count |
|---|